ROR1: an orphan becomes apparent

por Kipps, Thomas J.
Publicado 2022

Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway

por Hasan, Kamrul, Kipps, Thomas J.
Publicado 2023

Treatment of solid tumors with immunotoxins

por Messmer, Davorka, Kipps, Thomas J
Publicado 2005

Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia

por Rassenti, Laura Z., Kipps, Thomas J.
Publicado 1997

Wnt5a Signaling in Normal and Cancer Stem Cells

por Zhou, Yan, Kipps, Thomas J., Zhang, Suping
Publicado 2017

Corrigendum to “Wnt5a Signaling in Normal and Cancer Stem Cells”

por Zhou, Yan, Kipps, Thomas J., Zhang, Suping
Publicado 2017

Recent Advances in CAR T-Cell Therapy for Patients with Chronic Lymphocytic Leukemia

por Heyman, Benjamin M., Tzachanis, Dimitrios, Kipps, Thomas J.
Publicado 2022

Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter’s Syndrome

por Heyman, Benjamin M., Choi, Michael Y., Kipps, Thomas J.
Publicado 2022

Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells

por Hasan, Md Kamrul, Rassenti, Laura, Widhopf, George F., Yu, Jian, Kipps, Thomas J.
Publicado 2018

Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism

por Hasan, Md Kamrul, Ghia, Emanuela M., Rassenti, Laura Z., Widhopf, George F., Kipps, Thomas J.
Publicado 2020

A general process for the development of peptide-based immunoassays for monoclonal antibodies

por Sanchez, Ana B., Nguyen, Tammy, Dema-Ala, Rhanika, Kummel, Andrew C., Kipps, Thomas J., Messmer, Bradley T.
Publicado 2010

Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias

por Sattari, Arash, Siddiqui, Hasan, Moshiri, Farzaneh, Ngankeu, Apollinaire, Nakamura, Tatsuya, Kipps, Thomas J., Croce, Carlo M.
Publicado 2016

Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis

por O'Hayre, Morgan, Salanga, Catherina L., Kipps, Thomas J., Messmer, Davorka, Dorrestein, Pieter C., Handel, Tracy M.
Publicado 2010

Cirmtuzumab inhibits ibrutinib-resistant, Wnt5a-induced Rac1 activation and proliferation in mantle cell lymphoma

por Yu, Jian, Chen, Yun, Chen, Liguang, Zhang, Ling, Rassenti, Laura Z., Widhopf, George F., Kipps, Thomas J.
Publicado 2018

RITUXIMAB IN COMBINATION WITH HIGH DOSE METHYLPREDNISOLONE FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

por Castro, Januario E., James, Danelle F., Sandoval-Sus, Jose D., Jain, Sonia, Bole, Janet, Rassenti, Laura, Kipps, Thomas J.
Publicado 2009

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia

por Ghia, Emanuela M., Rassenti, Laura Z., Choi, Michael Y., Quijada-Álamo, Miguel, Chu, Elvin, Widhopf, George F., Kipps, Thomas J.
Publicado 2022

B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities

por Kluckova, Katarina, Clear, Andrew J., D’Avola, Annalisa, Rassenti, Laura Z., Kipps, Thomas J., Gribben, John G., Riches, John C.
Publicado 2022

A large fraction of trisomy 12, 17p(−), and 11q(−) CLL cases carry unidentified microdeletions of miR-15a/16-1

por Pepe, Felice, Rassenti, Laura Z., Pekarsky, Yuri, Labanowska, Jadwiga, Nakamura, Tatsuya, Nigita, Giovanni, Kipps, Thomas J., Balatti, Veronica, Croce, Carlo M.
Publicado 2022

Wnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasis

por Hasan, Md Kamrul, Widhopf, George F., Zhang, Suping, Lam, Sharon M., Shen, Zhouxin, Briggs, Steven P., Parker, Barbara A., Kipps, Thomas J.
Publicado 2019

Ethacrynic Acid Exhibits Selective Toxicity to Chronic Lymphocytic Leukemia Cells by Inhibition of the Wnt/β-Catenin Pathway

por Lu, Desheng, Liu, Jerry X., Endo, Tomoyuki, Zhou, Haowen, Yao, Shiyin, Willert, Karl, Schmidt-Wolf, Ingo G. H., Kipps, Thomas J., Carson, Dennis A.
Publicado 2009